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The Scottish NHS: meeting the financial challenge 
ahead 
 
James Barbour, Alec Morton, Laura Schang 
 
 
 
Abstract 
 
 
The Scottish NHS faces a crisis of affordability in the next couple of decades as the population 
ages and demands on services  intensify. This  presents two challenges: the first is how to 
redesign services to achieve greater efficiencies, and the second is how to engage the public so 
that there is a realistic public view about what is affordable, against which a mature discussion 
about the hard choices about funding and provision can take place.  We refer to these as the 
innovation and openness challenges.  In the paper we outline the current state of the system and 
discuss possible policy options. We conclude with some recommendations for next steps. 
 
 
1. Introduction 
 
 
As one of the four countries of the UK, Scotland is a proud inheritor of the original ³National Health 
Service´ or NHS.  The reason for the enduring popularity of the NHS in Scotland and indeed in the other 
countries of the United Kingdom is that it is a mechanism for providing universal coverage, enabling 
³everyone to obtain the services they need at a cost that is affordable to themselves and to the nation as 
a whole´ (WHO, 2013).  Universal coverage has been described by Margaret Chan, the Director of the 
World Health Organisation (WHO), as ³Whe single most powerful concept that public health has to offeU´
but this, if anything understates its importance: it has become a central idea in the political history of the 
last sixty years, as one country after another has made the journey to universal coverage, many inspired 
by the example of the UK. 
 
 
A challenge facing virtually all high-income countries, however, is how to continue to provide universal 
coverage as their populations age over the next couple of decades.   This applies whether or not 
countries have implemented universal coverage through NHS-like systems, which are funded out of 
general taxation, or social insurance systems on the German model, where people are enrolled with a 
social insurance fund (typically prevented from discriminating on the basis of pre-existing conditions to 
ensure universality). It also applies irrespective of the ownership structure of hospitals, the existence or 
otherwise of a split between purchasers and providers, the details of the financing mechanism, and so 
on. 
 
 
Domestically, the Scottish NHS has become a central battleground in the recent independence 
referendum with both sides arguing that the Scottish NHS and the communitarian values which underpin 
it would be best protected under their preferred constitutional arrangements. This debate has 
underscored the popularity of universal coverage: it is an idea with deep and passionate support, and 
the NHS, which instantiates it, is regarded with passionate devotion. 
  
 
 
 
 
During the Scottish independence campaign, various claims were made about the NHS. Future viability 
and levels of funding were debated. A leaked discussion paper, apparently prepared for NHS Scotland 
Chief Executives (reported by BBC Scotland, 16/09/14) argued ³The status quo and preservation of 
existing models of care, are no longer options, given pressures we face´ As reported, the paper alleged 
a funding gap of £400m for the coming year.  Such concerns are not confined to Scotland. In an open 
letter to the UK Prime Minister (The Independent, 05/10/14) the Chair of the British Medical Association 
and Leaders of Medical Royal Colleges and Charities wrote ³The NHS and our Social Care Services are 
at breaking point and things cannot go on like this´ The letters claims a funding deficit of £30bn by 2020. 
In the USA, which spends almost double on health care compared to the UK, 16.9% of GDP against 
9.3% in 2012 (OECD, 2014) a leading physician Director has described the need to reduce spending on 
health care, as ³The central domestic challenge of our time. It is not only harming families and choking 
our economy, but it also threatens our national well-being and economic security´&ochran and Kenney, 
2014). 
 
 
We believe the Scottish Government has been on balance a good steward of the NHS over the last 
several years: realistic in its assessment of the future challenges facing the system and responsible in 
providing a consistent policy framework for the development of the system in the years since devolution. 
However, given that the referendum has now happened, now is a good time to look at the long term 
prospects for the system.  In this paper we take the opportunity to look beyond the next few years, to the 
mid-2030s. Unfortunately in the years to come the pressures on the system from demographic and 
technological change look set to intensify.  We believe that the Scottish NHS will continue to exist, but 
services will look different and, indeed, the contract between government and citizens will have to be 
different. In this paper we explore a few options and scenarios. 
 
 
In Section 2, we review where the Scottish NHS is currently, noting that demographic change will 
present the system with demands substantially in excess of those which it is able to deal with currently. 
One way to respond to these pressures is to seek to make the system more efficient, that is to say its 
ability to service needs with existing inputs can be enhanced. This seems unlikely to be possible without 
significant innovation, and service redesign and consolidation ± we review some of the ways in which 
this innovation challenge can be met in Section 3.  However, even with significant innovation, the 
coming resource pressures mean that the public will have to face up to what their tax money can and 
cannot buy for them.  In Section 4, we discuss some ways in which this openness challenge could be 
addressed. 
 
 
2. Background: The Scottish NHS now 
 
 
Following devolution in 1999, the Scottish NHS has benefitted from relative organisational stability and a 
consistent policy focus on improving population health, reducing health inequalities and enhancing the 
quality of healthcare (for an in-depth review of the Scottish health system and policy developments, see 
Steel and Cylus, 2012). In 2010, the Healthcare Quality Strategy reaffirmed commitment to a 
comprehensive service that is effective, safe and person-centred (Scottish Government, 2010). Progress 
has been made in relation to each of these ambitions. For example, healthcare associated infections 
  
 
 
 
 
and rates of emergency bed days have fallen considerably. 
1  
The current reform agenda seeks to 
strengthen health and social care integration and aims to shift the balance of care away from episodic, 
acute care in hospitals towards preventive medicine and support for self-care in the community for the 
rising number of people with long-term and complex conditions (NHS Scotland, 2013). However, flat 
funding with increasing demand poses a challenge to the financial sustainability of the system. This 
section sets out the scale and nature of the financial challenge the Scottish NHS will be facing over the 
next years and reviews what has been achieved so far. 
 
2.1. Level of spending on health and the funding µJap¶ 
 
 
In 2012/2013, the Scottish Government allocated £11.58 billion (about 41% of its budget) for health 
(Scottish Government, 2012). Between 2000 and 2009, public spending on health more than doubled in 
cash terms and increased by almost 40% in real (inflation-adjusted) terms (Audit Scotland, 2009). Since 
then the annual rate of growth has been declining and the Scottish Government¶s budget plans for 2012 
to 2014 set out a nominal growth of between 1.2% and 1.9% per year. This entails a real decrease of 
2.8% over this timeframe (Scottish Government, 2011). 
 
 
In international comparison, the United Kingdom as a whole spent about 9.3% of its Gross Domestic 
Product (GDP) on health in 2012 (OECD, 2014). This is similar to the Nordic countries Finland, Norway 
and Sweden (with about 9.1%, 9.3% and 9.6% of GDP, respectively, in 2012). However, there is a gap 
with  respect  to  some  countries  with  competitive  economies  including  Denmark,  Germany  and 
Switzerland (with about 11%, 11.3% and 11.4% of GDP, respectively, in 2012 (OECD, 2014), indicating 
that  higher  expenditure  on  healthcare  does  not  necessarily  inhibit  economic  performance.  In  this 
respect, Scotland may have some headroom to increase spending on health to meet the financial 
challenges ahead; provided that, crucially, the resources that are currently in the system are effectively 
used, and that any extra resources are invested in high-value care to improve population health and 
reduce health inequalities. 
 
 
Table 1 Government spending on health per head in the United Kingdom, by nation 2000/01 and 
 
2012/13 [percentage spending relative to Scotland] 
 
 
Scotland England Wales Northern Ireland 
 
 
2012/13 £2072 £1,912 [92%] £1,954   [94%] £2,109   [102%] 
 
 
2000/01 £1,064 £891 [84%] £985 [93%] £1,099   [103%] 
 
 
Source: adapted from Bevan et al (2014). 
 
 
 
 
 
1 Between 2007 and 2012, Clostridium difficile infections fell by 78% and Staphylococcus aureus (MRSA/MSSA) 
bacteraemia fell by 37%. Over the same period, there was a 12% reduction in rates of emergency bed days for 
people over 75 years from about 5,466 to 4,814 per 1,000 population. See Health Protection Scotland (2014) and ISD 
(2013). 
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NHS and Special Health Boards 
 
Primary and Community Care Services 
 
1,388.00 
 
11.98 
Capital 453.5 3.92 
Improving health and better public health 226.7 1.96 
Education and Training 179.6 1.55 
NHS Impairments 100 0.86 
eHealth 90.3 0.78 
Research 69.5 0.60 
Clean Hospitals/MRSA Screening Programme 28.4 0.25 
Access Support (waiting times management) 27.1 0.23 
Distinction Awards 24 0.21 
Quality and Efficiency Support 18.9 0.16 
Self-Directed Support Programme 5.5 0.05 
Other 109.20 0.94 
Total 
 
Source: Scottish Government (2011a). 
11,583.00 100.00 
 
 
 
 
 
Compared to the other countries of the United Kingdom, public spending on health per head in Scotland 
was second highest after Northern Ireland in 2012/13. Over the years since 2000/01, the spending 
differential to England, Wales and Northern Ireland has narrowed (Table 1). 
 
 
In Scotland, health is the only policy sector with an increasing resource budget (in cash terms) over the 
current spending period to 2015. This is due to the Scottish Government¶s decision to pass on increased 
funding  from  the  Barnett  consequentials 
2  
in  full  following  the  Department  of  Health  2010  UK 
Comprehensive Spending Review (Scottish Government, 2011b). 
 
 
However, this protection of the health budget is relative: in the face of inflationary pressures arising from 
demographic changes, pharmaceutical and staff costs, the Scottish Government estimates that the NHS 
will need to make efficiency savings of at least 3% of allocated baseline funding to break even and meet 
rising demand for services (Scottish Government, 2011). At the beginning of 2012/13, the 14 territorial 
NHS  boards  forecast  they  would  need  to  achieve  savings  of  £271.7  million  to  break  even.  This 
amounted to 3.1% of the baseline revenue budget across all boards (with substantial geographic 
variation ranging from 1.7% at NHS Grampian to 7.1% of allocated baseline funding at NHS Shetland; 
Audit Scotland, 2013). There are therefore, significant challenges to financial sustainability even in the 
near term. 
 
 
Table 2 Budget plans for Scottish Government spending on health, 2012/13 
 
 
£m % 
 
8,862.30 76.51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 For each extra pound spent on a public service in England, the devolved governments in Scotland, Wales and 
Northern Ireland receive increases in their block grants proportionate to the size of their population. While this funding 
is not earmarked for the public service to which it was allocated in England, the Scottish Government has pledged to 
pass on in full the health related shares. 
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2. 2. Distribution of expenditure on health 
 
 
Of the £11.58 billion budgeted for health in 2012/13, just over 76% consists of baseline allocations to the 
 
14 territorial NHS boards and the nine special health boards (Table 2). The rest is transferred to boards 
for specific programmes or spent directly by the Scottish Government. 
 
 
In 2012/13, about £10.20 billion was spent on care directly provided to patients in hospital, community 
and family health services within the 14 health board areas and at two special boards, the State Hospital 
and Golden Jubilee National Hospital. Figure 1 shows how this expenditure is distributed between 
sectors. This illustrates that, despite the national strategy to move care to the community, the Scottish 
NHS is, in terms of its resource use, still dominated by the hospital sector. 
 
 
The share of the budget spent on different sectors of care has remained largely constant between 
 
2008/09 and 2012/13: from 57.8% to 57.0% on hospital care; from 15.0% to 16.4% on community care; 
from 23.9% to 23.3% on family health services; and from 3.4% to 3.3% spent on resource transfers to 
local authorities in support of community care services. 
 
 
Nevertheless, in nominal terms, all sectors have seen increasing expenditure over the period from 
 
2008/09 to 2012/13, albeit at different rates of growth (ranging from +7% in family health services and 
 
+8.1% in hospital care to +20.3% in community care). In real terms, there is evidence of a modest 
resource shift between community and hospital care: spending on hospital care has declined by -1.5% in 
real terms between 2008/09 while expenditure on community care increased during that period by 
+9.6% in real terms. Extra resources spent on community care largely went into three areas of 
expenditure: 
 
 pharmacy (up by 35% in real terms compared to 2008/09); 
 
 allied health professions and other paramedical staff (up by 15%); and 
 
 administrative costs (up by 8%). 
 
 
Figure 2 shows the amount and share of health spending by category in 2012/13, plus percentage 
changes since 2008/9. Staff costs continue to make up the largest item of spending, over two thirds of 
expenditure on hospital and community care. Almost 12% was spent on prescription drugs and 
associated pharmacy spending, an increase by 11.2% in real terms (22.1% in cash terms) compared to 
2008/09.  This  means  that  pharmacy  spending  was  the  only  category  with  real-term  increases  in 
spending over that four-year period. 
 
 
Drug costs are often regarded as an easy place to look for short term savings so it is worth drilling down 
in more detail.   Although general practice accounts for the largest net prescribing cost (about £1.12 
billion in 2012/13), spending has decreased in cash and real terms compared to 2011/12. This is linked 
to a drop in the cost per item of high volume proprietary costs which came off patent during 2012. These 
drugs could hence be substituted with cheaper generic alternatives (e.g. Atorvastatin for the lowering of 
blood cholesterol to prevent events associated with cardiovascular disease; ISD 2014a). 
November 2014 131 
 
 
 
 
 
 
 
 
Figure 1 Distribution of health spending in Scotland and percentage changes between   2008/9 and 
 
2012/13, by sector (s14 territorial NHS boards, Golden Jubilee Hospital and the State Hospital) 
 
£0.3bn, 3.3% 
 
Hospital sector (down -1.5% in real 
terms from 2008/09) 
 
£2.34bn, 23.3% Community sector (up +9.6% in real 
terms from 2008/09) 
 
 
1.68bn, 
16.4% 
£5.81bn, 57.0% Family health sector (down -2.6% in 
real terms from 2008/09) 
 
Resource transfer to local authority 
(down -1.1% in real terms from 
2008/09) 
 
 
 
Source: ISD (2013). 
 
 
 
 
Figure 2 Distribution of health spending in Scotland, plus percentage changes (2008/9 and  2012/13), 
 
by category (hospital and community care) 
 
 
 
 
 
 
 
£0.74bn, 
10.2% 
 
£0.81bn, 
11.2% 
 
 
 
 
£0.86bn, 11.9% 
 
 
 
 
 
 
 
£4.82bn, 66.7% 
Staff (down -0.9% in real terms 
from 2008/09) 
 
 
Pharmacy (up +11.2% in real 
terms from 2008/09) 
 
 
Administration (down -3.6% in 
real terms from 2008/09) 
 
 
Facilities (down -2.1% in real 
terms from 2008/09) 
 
 
 
 
Source: ISD (2013). 
 
 
 
 
The growth in pharmaceutical expenditure (Figure 2) is largely driven by prescribing in hospital, in 
particular spending on high-cost, low-volume (HCLV) drugs (Table 3). In 2012/13, NHS Boards spent 
over £115 million on the top ten HCLV drugs, a third of total pharmaceutical expenditure in hospital. 
These are expensive specialist drugs which are provided in hospital for cancer, irritable bowel conditions 
(anti-TNFs) and rheumatic conditions for comparatively few patients. Expenditure on these drugs tends 
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to increase at a faster rate than other drugs and is also less predictable, hence creating a particular cost 
 
pressure on NHS boards (Audit Scotland, 2013). 
 
 
 
 
Table 3 Changes in NHS pharmaceutical expenditure in Scotland, 2010/11 ± 2012/13 
 
 
 
 
Top 10 HCLV drugs 
 
Change in total spending 
2010/11 to 2011/12 
a
 
 
Change in total spending 
2011/12 to 2012/13
b
 
 
Cash terms £12.2 million (+15%) £13.5 million   (+13%) 
Real terms £10.4 million (+15%) £12 million  (+12%) 
All hospital drugs 
 
Cash terms £13.4 million (+5%) £28.2 million   (+9%) 
Real terms £7 million (+2.4%) £23 million  (+7%) 
All GP Drugs 
Cash terms £12 million   (+1%) £60 million  (-6%) 
Real terms £11 million   (-1%) £74 million  (-7%) 
 
 
Source: Audit Scotland 2012/13 
Notes: 
a  
Spending on HCLV drugs and all hospital drugs excludes NHS Highland and NHS Tayside; 
b 
Spending on 
HCLV drugs and all hospital drugs excludes NHS Tayside as data are currently being processed by ISD Scotland. 
 
 
2. 3. Key drivers of expenditure growth and financial sustainability 
 
 
The growth of public expenditure on healthcare is influenced by several determinants that affect the 
demand and supply of health services (European Commission and Economic Policy Committee, 2012): 
 
Demand side factors may include demographic changes, related changes in health status, 
regulations and entitlements governing access to healthcare, and changing expectations about 
standards of care; 
 
Supply side factors may include costs associated with new health technologies (in particular 
pharmaceuticals), staff costs, and the organisation of service provision. 
 
 
In this section we focus on the demand-side factors as the supply side factors are to a large extent a 
function of policy action, which is the focus of the next two sections. 
 
 
Rising demand: ageing of the population 
 
 
Between 2012 and 2032, the share of people aged 65 years and over is projected to grow substantially 
(Figure 3). In contrast, the population of working age (16 to 64 years) is expected to remain stable or (in 
the group aged 16 to 29 years) even decline. 
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Figure 3 ScotlanG¶s population by selected age groups , 2012 and 2032, plus  percentage change 
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200 
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2012 2032 
 
Source: authors¶ estimate based on General Register for Scotland (2014). 
 
 
These trends pose two challenges for the financial sustainability of the health service. 
 
 
First, in terms of revenue from taxation, an increasing share of older people increases the old age 
dependency ratio, i.e. fewer contributors in relation to the beneficiaries of services. In Scotland, the old 
age dependency ratio is expected to grow by about 65% between 2012 and 2037 from 27 to 41 people 
over 65 years for 100 people in working age (15-64 years). Consequently, fewer people will pay taxes to 
finance public health care. 
 
 
Second, because spending rises steeply with age, population ageing can be expected to lead to rising 
health and social care expenditure. In 2012, people over 65 years made up about 17% of the Scottish 
population, but accounted for 33% of NHS operating costs (about £3.37 billion). Integrated mapping of 
resource use across health and social care shows that the NHS and local authorities  spent about $4.61 
billion for people over 65 years in 2012/13. Almost a third of this expenditure was consumed by 
emergency admissions to hospital (authors¶ estimate based on ISD, 2014b). The Scottish Government 
forecasts that, by 2031, almost £8 billion will be required to finance health and social care for older 
people (Figure 4). This assumes no changes in age/sex specific costs of health and social care (i.e. no 
improvement in the health of the population or in quality-adjusted efficiency of service delivery). 
 
 
However, predicting future spending needs is fraught with methodological issues and controversies. 
Macroeconomic models (Lisenkova et al., 2010; Lisenkova and Mérette, 2013) show that the impact of 
population ageing on economic development and on labour income tax rates required to ensure a 
balanced government budget is highly sensitive to population projections and net migration. 
 
 
In its 2012 Ageing Report, the European Commission and the Economic Policy Committee (2012) 
 
estimate a range of scenarios  for future healthcare spending and sensitivity to alternative sets  of 
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assumptions regarding future burdens of disease, income elasticity and technological change. This 
shows that whilst ageing per se does drive expenditure growth to a non-negligible extent, a key source 
of uncertainty is whether gains in life expectancy are spent in good or bad health. If disability is 
compressed towards the end of life at a faster pace than mortality (the so-called ³compression of 
morbidity´ hypothesis (Fries, 1989)), then increasing longevity entails an increasing number of health life 
years and this may moderate the additional cost burden from ageing (and indeed provide greater 
opportunity for older people work beyond statutory retirement). In contrast, the ³expansion of morbidity´
hypothesis (Olshansky et al., 1991) states that falling mortality goes in line with an increase in morbidity 
and disability. Empirical research (Global Forum for Health Research, 2008)  on the validity of these 
hypotheses is inconclusive, and suggests potentially counter-balancing effects of rising rates of some 
disabling conditions (dementia, musculoskeletal diseases) and declining prevalence rates of others 
(cardiovascular and chronic respiratory diseases). Finally, many factors ± in particular the long-term 
spending impact of technological change as a cost-increasing or cost-decreasing variable ± are 
endogenous and dependent on Government policy decisions. 
 
 
Though we therefore cannot know for certain what the exact future funding requirements for healthcare 
are, it is clear that healthcare expenditure can be expected to increase into the future. 
 
Figure 4 Health and Social Care resource use: projected increases for people aged 65 and over, 2007/8 
to 2030/31 
 
8.0 
 
7.0 
 
6.0 
 
5.0 
 
4.0 
 
3.0 
 
2.0 
 
1.0 
 
0.0 
2007/08 actual 2011 2016 2021 2026 2031 
 
Emergency admissions other NHS Home care Care Homes Other social work 
 
Source: Scottish Government, COSLA and NHS Scotland (2010). 
 
 
2. 4. Efficiency savings: what has been achieved and how? 
 
 
For 2012/13, the NHS in Scotland as a whole achieved savings of 3% of baseline funding, as required 
by the Scottish Government, and 99% (£269.8 million) of its own forecast savings target of £271.7 
million (Audit Scotland, 2013). Since 2009, local actions to reduce costs while improving the quality of 
healthcare have been supported by a national Efficiency and Productivity Framework (Scottish 
Government,  2011b).  In  2012/13,  savings  were  achieved  mainly  through  changes  in  prescribing 
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behaviour (for example by means of generic prescribing through the operation of the Scottish Tariff) and 
clinical productivity (which includes changes in acute flow and capacity management; Figure 5). 
 
 
Figure 5 Efficiency savings reported by NHS boards, by workstream, 2012/13 
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Source: Scottish Government (2014a). 
 
 
On average, 78% of savings reported by boards were recurring in 2012/13, meaning that savings 
achieved recur year on year (e.g. lower staff costs due to better streamlined processes). However, some 
boards continue to rely on a large proportion (up to 56%) of non-recurring savings (e.g. those derived 
from the sale of fixed assets, such as buildings); these one-off savings risk being unsustainable in the 
future (Audit Scotland, 2013). Moreover, 66% of savings required for 2014/15 are still unidentified. This 
amount increases to 73% for 2015/16. Thus, for just two years ahead, boards have not determined how 
or where they will release more than two-thirds of the savings needed to break even, suggesting a lack 
of planning how to achieve sustainable financing over the long term (Audit Scotland, 2013). 
 
 
In 2013, the Scottish Government¶s Route Map to the 2020 vision (NHS Scotland, 2013) set out key 
deliverables for 2013/14 to enhance the financial sustainability of the system. These include a new 
innovation fund to provide pump-priming for innovations that enable Scottish small and medium sized 
enterprises (SMEs) to collaborate with NHS Scotland to test approaches that improve the quality of care 
and foster economic growth, as well as efforts to scale up shared services (including the reduction of 
drug costs through a single, coordinated programme at national level). However, as should be evident 
from the previous subsection, the system faces ever more pressing challenges to its long term 
sustainability over the next decade or two.  It seems likely that once the one-off gains from picking the 
'low hanging fruit' have been harvested, deeper policy and operational innovations will be needed to 
transform the health service for the years to come. 
 
3. The innovation challenge 
 
 
As health care systems in advanced economies across the world experience the same challenges of 
growing, ageing populations, rising levels of chronic conditions and ever increasing costs, there is a 
growing recognition that short-term cost cutting measures are no longer sufficient response. The 
challenge is now seen as how to change the way health care is delivered (Taunt et al., 2014). 
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Creating a system of health and social care which is patient centred, safe, accessible and affordable, 
requires the simultaneous pursuit of better quality of care, at lower costs.  Several barriers exist to 
achieving this goal. The lack of a detailed model for health care reform, which balances short term cost 
containment with longer-term goals, is one such barrier while the absence of a candid dialogue involving 
patients, professionals and communities is another. There is a need to gain acceptance from 
stakeholders that it is no longer sufficient to avoid future costs and that reduction of current costs is 
required, accompanied by a redirection of costs ± and care ± away from hospitals. As noted, in Scotland, 
the hospital share all of NHS expenditure currently stands at 57%, largely unchanged over the last five 
years (ISD, 2014). 
 
 
On their own, individual health care organisations have been historically unlikely to achieve radical 
service transformation, irrespective of the scale of financial challenge (Thirlby, 2011).  Scottish Health 
Chief Executives acknowledged in their leaked paper, that: ³%oards lack the mandate and ability to 
implement the scale of reform required´Ueported by BBC Scotland, 16/09/14).  To achieve a future state 
of high quality, affordable health care, service innovation is the key to future sustainability (Department 
of Health, 2011). 
 
 
In Scotland, many favourable conditions are already in place to help make a start in this necessary 
transition. High quality medicine in centres of excellence, and primary care, a large stable workforce, 
135,980 in 2014 up by nearly a third in 15 years, (Scottish Government, 2014c), comprehensive long- 
term data sets and a compact Public Sector, largely unaffected by continuing reforms, are in place. In 
relative terms, health services are well resourced, with more GPs, hospital doctors and nurses per 1000 
population than the rest of the UK (Bevan et al., 2014). And, following the referendum process, the 
country has been described as having one of the most politically engaged populations in Europe (Alex 
Salmond MP, First Minister¶s statement in the Scottish Parliament 23/09/14). These are all assets that 
Scotland can put to use, to create a sustainable health and social care service for its citizens. 
 
 
These  underlying  circumstances  support  the  task  of  translating  ³the  best  work  anywhere  into  the 
standard everywhere´ (Cochran and Kenney, 2014: 23), in the cause of achieving future sustainability 
through innovation.  An example of such µEest work¶ is the introduction of integrated care, defined as 
³planning and providing services to impose the patient perspective as the organising principle of service 
delivery´6haw et al., 2011: 7). 
 
As an example of an opportunity for learning, is the Kaiser Permanente health care system 
3 
.   Its 
systematic adoption of better-integrated care supports a range of acute hospital admissions that is 
around one third lower than that of the UK. Similarly, its length of hospital stay per 1000 of population, is 
3.9 days, against 5.7 in Scotland. Inpatient admissions in the Kaiser System are 69 per 1000 population, 
against 143 in Scotland. Acute bed days used per 1000 population are 270 in Kaiser, against 812 in 
Scotland (Bevan et al., 2014).  In the UK, the health care system in Torbay is achieving comparable 
benefits (Thistlethwaite, 2011). 
 
3 
Kaiser Permanente is a not for profit, integrated managed care consortium, based in Oakland, 
California. Founded in 1945, by industrialist Henry J Kaiser, and physician Sidney Garfield, it has an 
income of US$53bn, with 180,000 employees, including 15,000 physicians 
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Integrated care systems feature ³community navigators´ to co-ordinate health and social care systems 
and in Kaiser¶s system, ³community paramedics´ who can intervene and treat patients in crisis, where 
hospital admissions may otherwise be required. In Yorkshire, Airedale Hospitals have adapted the 
Kaiser model of using community nurses linked directly to doctors and hospital by skype and iPad. This 
approach has reportedly yielded a 60% reduction in hospital admissions (Financial Times 5/10/2014). 
Across the NHS, face to face contact accounts for 95% of all health care intervention and a reduction of 
1% of this activity is estimated to save £200m (Department of Health, 2011). In the USA, the culture of 
³presenteeism´ in hospitals is tackled through video conferencing with doctors and groups of patients, 
with health care provided where the patients live, work and play. 
 
 
Telehealth (the remote exchange of data between individuals and health care professionals as an 
assistance to diagnosis and treatment) and telecare (the use of remote monitoring to manage the risks 
of independent living) have benefited from £20m investment in Scotland over the past five years, 
affecting 44,000 patients. Benefits attributed to this investment focus on the avoidance of 8,400 
emergency  admissions  over  the  same  period,  according  to  the  National  Telehealth  and  Telecare 
Delivery Plan (NHS Scotland, COSLA and The Scottish Government, 2012). The Delivery Plan does not 
make a direct connection between telehealth and telecare and cost reduction, while acknowledging that 
further work is required ³WR establish a baseline and develop consistent outcome measures and 
indicators, to track the impact of telehealth and telecare, on working practices, productivity and resource 
use´ 
 
 
Statistically significant benefits in respect of reductions in admission levels and mortality have been 
reported  (Steventon  et  al.,  2012),  but  none  relating  to  cost  reduction.  No  significant  reduction  in 
demands on GP time was found. Innovation in telecare and telehealth has the potential to improve 
unnecessary hospital admissions but ³Uobust information on costs and outcomes is lacking´ (Clark and 
Goodwin, 2013: 3). In the Scottish context, telehealth and telecare initiatives are not yet part of a co- 
ordinated and systematic programme of integrated care and therefore are more likely in current form, to 
generate benefits in remote accessibility, rather than the more radical effects of disruptive technology 
now being seen elsewhere in the UK, and in the USA. 
 
 
In Scotland, the Public Bodies (Joint Working) (Scotland) Act 2014 allows for the establishment of 
Integration Joint Boards, with the organisational potential to support widespread adoption of integrated 
care innovations.  Alongside integrated care, the extensive mining of patient related data sets offers the 
opportunity to move care in Scotland from the industrial age to the information age. Data sharing with 
the patients at the centre is central to the success of initiatives in Torbay, resting on the principle 
³nothing about me, without me´ 
 
 
In many systems, data mining is already used by doctors to determine the best form of treatment for 
patients. It is also central to risk stratification of patients. In the USA, 5% of individuals incur half of all 
health  care  expenditure  (Cochran  and  Kenney,  2014:  21)  In  Airedale,  3%  of  patients  have  been 
identified as consuming 39% of resources (Financial Times 5/10/2014). Equivalent figures for Scotland 
do not appear to be readily available. Yet having such data is critical to identifying the patients who 
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cannot be discharged due to failings in the social care system: effectively medicalising (at great cost) 
social problems with roots that are outside the healthcare system.  At the aggregate level is the cost of 
this can be demonstrated by the most recent delayed discharge figures for Scotland, which show that 
against a target of no patient waiting longer than two weeks for discharge (a target not demanding by 
international standards and due to be introduced in 2015), 518 patients were awaiting discharge, 
amounting to around 150,000 lost bed days.  The need for approaches such as the Kaiser approach is 
apparent for older patients with complex needs, where increased longevity is accompanied by increased 
incidence of multiple conditions. In the USA, it is estimated that half of all people over the age of 75 have 
3 or more complex conditions (Goodwin et al., 2014). 
 
 
International models of Primary Care support the importance of the role of the General Practitioner or 
primary care physician, at the heart of an integrated, team based approach. The current status of 
General Practitioners as Independent Physicians, their existing workloads and remuneration 
arrangements, have the potential to inhibit their membership of integrated Teams. Correspondingly, 
³where care givers are working within common governance and incentives rules, facilitated through 
closer organizational partnership arrangements, then the more likely it seems that integrated care on the 
ground can be supported´ (Goodwin et al., 2014: 20).  A useful resource in this discussion is the recent 
report from King¶s Fund and the Nuffield Trust, which reviews a number of possible models of integrated 
primary care drawing on international experience (King¶s Fund and the Nuffield Trust, 2013). 
 
 
4. The openness challenge 
 
 
If it is not possible to find efficiency savings along the lines outlined in Section 3 to meet the challenges 
outlined in Section 2, additional revenue will have to be obtained from elsewhere.  However, health is 
the second largest budget category in the public sector accounts after welfare, and although spending 
on benefits is arguably less politically popular than health, large scale raids on the benefit budget (to say 
nothing of the pension budget) would clearly raise issues of their own, outside the scope of this note. 
Increasing general revenues would be another route.  Presumably raising significant additional financing 
would be well within the scope of powers of a future Scottish government with enhanced tax raising 
powers but public willingness to accept tax rises has yet to be tested.  A conceivable policy option (quite 
common in other European countries) would be to institute a hypothecated tax to pay for health services: 
this would create greater public visibility on the costs of the healthcare system specifically and limit the 
scope for political discretion (oU³interference´ in the allocation of funds. 
 
 
If money to cover the additional expenditure is not forthcoming from general tax revenues, there are as a 
matter of logic, a number of possible options.  These can be conceptualised through the famous cube of 
universal coverage promulgated by the WHO (2010).   Countries providing universal coverage must 
make decisions about: 
 
1. Who is covered? 
 
2. What fraction of expenditure is covered? 
 
3. What is covered? 
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Each of these dimensions of coverage drives cost and therefore countries wishing to reduce public 
expenditure must cut back on one of these dimensions. 
 
 
In terms of 1., there is the option of denying care to some people altogether.  As an example of this, 
Kentekenelis et al. (2014)   report that 800,000 people in Greece are now unemployed and without 
access to either unemployment benefits or health coverage, as a result of the government¶s austerity 
programme.  For them, health provision is only via  the voluntary sector.  Of all possible ways of dealing 
with a budget shortfall, this seems the worst ± a breach of the very principles of universal coverage itself, 
and a dereliction of society¶s duty to people at a time in their life when they are most in need. 
 
 
In terms of 2., a second option is cost-shifting to patients through imposition of or increases to user fees 
and co-payments.  Typically there is also some form of means testing to protect those who are unable to 
pay.  The recent history of Ireland an example of this approach close to home.  Altogether Thomas et al. 
(2014) estimate that on average every person in Ireland is paying an extra ¼0 in user fees compared 
to before the crisis, although of course this average masks the fact that older and sicker people will pay 
more and younger and healthier people will pay less. Although user fees are often advocated on the 
grounds that they reduce unnecessary care, the general thrust of the evidence is that user fees reduce 
both necessary and unnecessary care in a fairly indiscriminate fashion (Swartz, 2010).  What is certain 
is that compared to obtaining funds from general taxation, user fees disproportionately hit people who 
are unwell.  User fees may be a last resort means of funding, if there are political barriers to raising the 
funds through taxation, but should not be a seen as a sustainable solution. 
 
 
A third alternative is to restrict what is covered in the healthcare system (this is dimension 3. above), 
typically by ³impliciW´ rationing through imposing access restrictions such as waiting lists (Morton and 
Bevan, 2012).  Economically waiting lists are problematic as a means of rationing as they impose 
deadweight costs in the system.  Implicit rationing is also more acceptable in societies where it is 
accepted that ³doctor knows besW´but for better or for worse, modernity is associated with a decline in 
such deferential attitudes.    A related response to restricting coverage is to degrade the quality of the 
service offering.  Yet even if it were desirable to sanction clinicians cutting corners to reduce costs, this 
runs counter to the core principle of focussing on quality and patient safety which have been central to 
Scottish health policy discourse since devolution, and would risk undercutting the gains which have been 
made from the government¶s determined pursuit of this agenda. 
 
 
In view of the problems associated with implicit rationing, many countries in response to the austerity 
introduced by the financial crisis have introduced or strengthened explicit rationing of services through a 
defined benefit plan or ³positive lisW´ of treatments which patients are entitled to expect in the public 
system.  This is also a common feature in the systems of many middle-income countries (for example 
those in Latin America, see Giedion et al. (2014)) who have sought to introduce universal coverage but 
who are simultaneously acutely mindful of the budget constraints that such systems must operate under. 
An advantage of defined benefits plans is that they can be used throughout the planning process, both 
at the stage of budgeting and assessing public sector resource needs, as well as in monitoring system 
delivery.  Indeed, if there is agreement about what should be provided by the healthcare system, and for 
what indications, it should in principle be possible to monitor the volumes of services provided with what 
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is expected given population morbidity, and thus assess both under- and overuse of services ± see e.g. 
Schang et al. (2014) for an example of some modelling to support this sort of exercise in a paediatric 
ENT context. 
 
 
Defined benefit plans have the attractive feature that they make it clear to the taxpaying public what the 
system can and cannot afford and thus make it possible for citizens to make an informed decision about 
the right level of funding for the health service.  Scotland is in the fortunate position of having a suite of 
institutions which have a guideline development and technology assessment role: the Scottish 
Intercollegiate Guidelines Network (SIGN), the Scottish Medicines Consortium and the Scottish Health 
Technologies Group.  However, defining a benefits package which is robust is not merely a technical 
exercise: it requires strong processes which incorporate evidence and synthesise them with social 
values, and which can be shown to procedurally fair.  Although engaging members of the public and 
other stakeholders in deliberating about the key economic and ethical challenges is not easy, examples 
of good practice do exist (Daniels and Sabin, 2007; Gold et al., 2007; Airoldi et al., 2014).  Moreover, the 
National Institute of Clinical Excellence (NICE) in England has commissioned studies of population 
values as they relate to healthcare prioritisation (Edlin et al., 2012), and willingness to pay assessments 
for a quality adjusted life year (Donaldson et al., 2011, drawing on the expertise of Scottish researchers). 
If Scotland aspires to have a healthcare system which reflects her values, and to make a balanced and 
informed judgement about a socially acceptable /agreed  trade-off between additional expenditure and 
coverage and system reform, there is a clear need to establish more clearly what these distinctively 
Scottish values actually are, and involve wider stakeholders in decision making about the health system, 
so that the coming difficult decisions are taken in as robust, defensible and democratice manner as 
possible. 
 
 
5. Conclusion 
 
 
Although  we  have  rehearsed some  of  the  issues  and options  in this  paper,  we  do  not  have  the 
knowledge or the indeed the mandate to make detailed and specific recommendations about what 
should be done.  However, we consider that in charting a way forward, there are five important streams 
of activity which should be part of a credible response. 
 
 
Issue One: There should be a detailed and authoritative high level investigation of the scale of the 
funding gap between projected expenditure and healthcare financing needs which Scotland faces, 
chaired by an authoritative and credible figure. (A possible model is the Wanless Review (Wanless, 
2002)  in  England from some  years  ago).  Of  course,  as we  highlight  above,  the  methodology for 
 
assessing future healthcare financing is not a settled science: it is not the case that there a single 
number.      A  properly  rigorous  study  would  produce  a  range  of  estimates  which  reflect  genuine 
uncertainty about the way in which population morbidity and cost drivers will evolve, and so would 
command broad assent and credibility.  At the same time, such an assessment would provide Health 
Boards with the framework that they need to begin operational planning and would set the stage for an 
informed and realistic public discussion. 
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Issue Two: . There should be a concerted effort to strengthen leadership capability in the health 
service.     Clinical leadership in particular has a vital role.  In response to the calls from the BMA and 
Royal Colleges for an open debate about the future of the NHS in Scotland, doctors need to assume the 
role of ³accountable leaders´$V the Chief Executive of the Institute of Health Improvement describes it 
³We need doctors to be the leaders for whom µhanging onto the status qXRµ, is a betrayal of their 
patients´Maureen Bisognano, cited in Cochran and Kenney, 2014: 30). Indeed, in general, the delivery 
of better integrated care, based on innovative technology, new roles and personalisation of care across 
health and social care, will require new leaders and new leadership skills (Taunt et al., 2014). 
 
 
Although  integral,  clinicians cannot  lead  in  isolation.  The  leadership  cadre  in  the  public  sector  in 
Scotland is small and the number of leaders with the necessary experience to transcend organisational 
boundaries, even smaller.  Universities in Scotland, with their business schools and Innovation centres 
offer the potential to develop programmes of joint learning, which foster a culture of innovation and the 
confidence to navigate new models of governance. ³Mitigation Planning³ for the uncomfortable 
consequences of shifting resources away from the acute sector and the development of robust 
information sharing arrangements with the patient at the centre ³nothing about me, without me³ will also 
require focussed leadership. 
 
 
Issue  Three:.  There  needs  to  be  a  suite  of  tools  for  Health  Boards  to  shift  the  balance  of 
investment  in  local  health  economies,  making  difficult  but  necessary  decisions  such  as  closing 
inefficient facilities. Well-designed systems of integrated care, accompanied by innovative use of 
disruptive technology have the potential to release substantial monies from the acute sector (Bevan et 
al., 2014).  Yet in Scotland and in many other countries there is no validated approach for successful 
disinvestment (HealthPACT, 2013).  Working with universities and leading economists, Scotland could 
lead the way in developing an open and rigorous process for disinvestment and reinvestment, with 
accompanying metrics for assessing outcomes. To accompany innovation ³Ueverse innovation´ is 
required, offering a mechanism for stripping out activities, which no longer add value, or can be replaced 
by something better (Department of Health, 2011).  To realise benefits from new ways of working, 
existing spending must be treated as variable, when all too often it is seen as fixed (Kaplan et al., 2013). 
 
 
Strategic planning requires reality-proofed technical and process tools to support difficult decisions.  For 
example, the Journey Making approach (Ackermann and Eden, 2011) has a track record in supporting 
healthcare organisations to think about the formulation of strategy; the Program Budgeting and Marginal 
Analysis (Mitton and Donaldson, 2001) or the STAR approach sponsored by the Health Foundation 
(Airoldi  et  al.,  2014)  have  been  used  to  think  about  strategic  prioritisation  and  service  redesign. 
However, developing strategic planning competency is not ³plug and play´ learning about such 
approaches has to be done in a context where there is the provision of opportunities for senior staff to 
learn and develop the necessary skills alongside with their peers.   There needs to be a broader public 
national dialogue about what is affordable, what level of increased spending the public are prepared to 
bear, and how services are to be ³Uationed´ if the spending to meet the financial demands of providing 
existing levels of service to an older and hence sicker population. 
November 2014 142 
 
 
 
 
 
 
Issue Four:. International experience (Clemens et al., 2014) the importance of an open and honest 
debate, accompanied by broad and continuing stakeholder consultation and engagement, leading 
to a shared vision of the future state. This accords with the view of the BMA Scottish Chairman (Dr Peter 
Bennie, cited in the Scotsman 19/09/14). Politicians have to lead this debate but ultimately the whole of 
Scottish society will have to participate.  Here there are opportunities to learn from other areas of policy: 
for example, the UK government made a substantial commitment to engaging the public in a national 
debate about what should be done about the UK¶s radioactive waste in the middle of the last decade, 
and much could be learned from that exercise (Morton et al., 2009; Dietz and Morton, 2011).  Indeed, 
the Irish government appears to be contemplating a move towards an explicit ³health baskeW´ or health 
benefits plan, arrived at in a consultative fashion through the development of a guiding ³values 
framework´,rish Government Department of Health, 2014). 
 
 
Issue  Five:.  Implementing  a  shared  vision,  with  clinicians  leading  the  way,  is  more  likely  to  be 
successful, with the availability of a Transformation Fund, supporting the initiation of new services and 
the transition away from old ones (Taunt et al., 2014). As Scotland begins the process of being able to 
determine its own taxation levels, there is an opportunity to link revenue generated, to the evident public 
concern for the future sustainability of the NHS.  Delivery of new models of care, in accordance with a 
shared vision and facilitated by a Transformation Fund, could be seen as an early and legitimising task 
for the new Integration Joint Boards. These are to be responsible for adult social care, adult community 
services and a proportion of adult acute services. Their role is to ensure ³That health and social care in 
Scotland, is joined up and seamless´Scottish Government, 2014 (website)). 
 
 
This initiative has already attracted conflicting views. The Confederation of Scottish Local Authorities 
(COSLA) response to the consultation on the Public Bodies (Joint Working) (Scotland) Act highlights the 
need for the effective disinvestment and reinvestment mechanisms: ³Integration authorities must have 
sufficient control of the means to shift the balance of care from acute to community setting and take 
demand out of the system³ (COSLA response 2/6/2014 ± authors¶ italics) By contrast the BMA response 
suggests that: ³,W will be difficult to support the shift of resource between health care and social care 
without an adverse impact on care´ (BMA response 23/9/2014). Even Audit Scotland is unclear on the 
effects on hospitals (Audit Scotland response July 2014). 
 
 
In conclusion, the delivery of health and social care which is safe, timely, effective, efficient, patient 
focussed and also affordable is a huge task.  Our forebears have bequeathed us a healthcare system 
based on the principles of universal coverage which has been both resilient over decades and a source 
of global inspiration.   In Scotland, today, politicians, clinicians and health care leaders have the 
opportunity, in the words of Jonas Salk, discoverer of the first polio vaccine, to demonstrate that: ³Our 
greatest responsibility is to be good ancestors´ that we have the courage and imagination to reinvent 
the universal coverage so that it is sustainable for future generations, and to do so in a way which 
remains faithful to the distinctive values of the Scottish people. 
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